Can I safely taper off alprazolam (Xanax) and then start eszopiclone (Lunesta) for insomnia?

Can You Titrate Off Xanax and Start Lunesta?

Yes, you can safely taper off alprazolam (Xanax) and transition to eszopiclone (Lunesta) for insomnia, but this requires a gradual benzodiazepine taper rather than abrupt discontinuation, and eszopiclone can be overlapped during the taper to help manage withdrawal symptoms.

The Critical Issue: Benzodiazepine Withdrawal

Alprazolam is a benzodiazepine that should never be stopped abruptly after more than 1-2 weeks of use. The evidence is clear that benzodiazepines cause dependency and produce significant withdrawal symptoms 1. A recent 2026 guideline on switching hypnotics emphasizes that benzodiazepine receptor agonists must be tapered gradually after medium- or long-term use (>2 weeks), with a weekly dose reduction of 10-25% 2.

Specific Tapering Protocol

• If used ≤2 weeks: Can discontinue abruptly
• If used >2 weeks: Reduce dose by 10-25% weekly
• If used at high doses (≥2/3 maximum) or ≥1 year: Use a longer, more conservative taper

The 2026 guideline specifically notes that withdrawal symptoms from benzodiazepines can be alleviated with overlapping administration of eszopiclone 2, making this transition strategy evidence-based.

Why Eszopiclone is an Appropriate Alternative

Eszopiclone is recommended by major guidelines as a treatment option for insomnia, unlike benzodiazepines which are explicitly advised against 1, 3. The American Academy of Sleep Medicine suggests using eszopiclone for both sleep onset and sleep maintenance insomnia at doses of 2-3 mg 3.

Key Advantages of Eszopiclone Over Alprazolam

• No tolerance development: Studies up to 12 months show sustained efficacy without tolerance 4, 5, 6
• Minimal rebound insomnia: Unlike alprazolam which causes significant rebound insomnia upon withdrawal 7, eszopiclone shows little to no rebound effect 6
• Lower dependency risk: While still a controlled substance (C-IV), eszopiclone has a more favorable safety profile 8
• Better sleep architecture: Does not significantly alter slow-wave or REM sleep like benzodiazepines 5

Practical Transition Strategy

Step 1: Initiate Alprazolam Taper

Begin reducing alprazolam by 10-25% weekly. For example, if taking 1 mg nightly, reduce to 0.75 mg for week 1, then 0.5 mg for week 2, etc.

Step 2: Overlap with Eszopiclone

Start eszopiclone during the taper phase to manage withdrawal symptoms and maintain sleep quality 2. The FDA-approved dosing is:

• For sleep onset difficulty: Start 1 mg at bedtime 8
• For sleep maintenance difficulty: Start 2 mg at bedtime 8
• Maximum dose: 3 mg (for non-elderly adults) 8

Step 3: Complete Alprazolam Discontinuation

Continue tapering alprazolam to zero while maintaining eszopiclone therapy.

Critical Safety Warnings from FDA Label

The Lunesta FDA label contains important warnings 8:

• Do NOT take with other sedating medications during the transition (this creates a challenge—you'll need to balance the taper carefully)
• Complex sleep behaviors: Risk of sleep-driving, sleep-walking while not fully awake
• Take only when able to get 7-8 hours of sleep
• Take on an empty stomach (not with or after meals)
• Higher risk of adverse events when combined with alcohol or other CNS depressants

Common Pitfalls to Avoid

1. Stopping alprazolam too quickly: This causes severe withdrawal including anxiety, rebound insomnia, and potentially seizures in extreme cases
2. Taking both medications at full dose simultaneously: The FDA label warns against combining eszopiclone with other sedating medications 8
3. Expecting immediate equivalence: Alprazolam has rapid tolerance development 7, so you may have been taking it without full efficacy; eszopiclone may feel different initially
4. Not addressing underlying causes: The 2020 VA/DoD guideline emphasizes that behavioral interventions (CBT-I) are more effective than pharmacotherapy 1—consider adding this

Monitoring During Transition

Watch for:

• Benzodiazepine withdrawal symptoms: Anxiety, tremor, insomnia worsening, agitation
• Eszopiclone side effects: Unpleasant taste (most common), drowsiness, dizziness 8, 6
• Complex sleep behaviors: Any reports of activities during sleep
• Efficacy: Sleep should improve within 7-10 days; if not, reassess 8

Special Considerations

If elderly (≥65 years): Start eszopiclone at 1 mg regardless of sleep complaint type, as elimination half-life increases to 9 hours in older adults 5, 9. The taper should be even more conservative.

If liver disease: Reduce eszopiclone dose; severe hepatic impairment requires significant dose reduction 5.

Cognitive behavioral therapy: Should be offered concurrently, as it reduces relapse risk (RR 1.68) 2 and is the preferred first-line treatment 1.